Skip to content

ashwattha pallava churna in medoroga with special referance to dyslipidemia

A randomized open labelled single arm clinical study of Ashwattha pallava churna in Medoroga with special reference to Dyslipidemia - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071727
Enrollment
40
Registered
2024-07-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E788- Other disorders of lipoprotein metabolism

Interventions

None listed

Sponsors

Dr. Sahil Bhavsar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)BMI between 25 to 38.9 kg/m2 . 2)Dyslipidemia associated disorders like Non-insulin dependent diabetes mellitus [NIDDM]- RBS up to 200 mg/dl. Coronary artery disease [CAD] P/H/O myocardial infarction Hypertension B.P. up to 160/100 mmHg

Exclusion criteria

Exclusion criteria: 1)Patients with HIV, HbsAg or any infective disorders 2) Patients undergone cardiac surgeries like coronary artery bypass graft [CABG], angioplasty, open heart surgery etc. 3)BMI less than 24 kg/m2 and more than 39 kg/m2 . 4)Chronic severe disorders like Chronic renal failure. Severe type 2 diabetes mellitus- RBS more than 200mg/dl. Severe hypertension – more than 160/100 mmHg.

Design outcomes

Primary

MeasureTime frame
Lipid profileTimepoint: 3 months

Secondary

MeasureTime frame
All outcomes which effect the quality of life.Timepoint: 6 months

Countries

India

Contacts

Public ContactDr Madhav Diggavi

Taranath Government Ayurvedic medical College and Hospital

rsganiger@gmail.com9448234194

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026